Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Guido Ventroni is active.

Publication


Featured researches published by Guido Ventroni.


European Journal of Nuclear Medicine and Molecular Imaging | 1999

Value of the first serum thyroglobulin level after total thyroidectomy for the diagnosis of metastases from differentiated thyroid carcinoma.

Giuseppe Ronga; Mauro Filesi; Guido Ventroni; Anna Rita Vestri; Alberto Signore

Abstract. The aim of this study was to evaluate the diagnostic significance of the first serum thyroglobulin (Tg) measurement, performed 40 days after total thyroidectomy for differentiated thyroid carcinoma and prior to the ablation of residual thyroid tissue by means of iodine-131 therapy. In a retrospective study we examined 334 consecutive patients followed up for 4–16 years by means of regular Tg measurements, 131I whole-body scans (WBS) and other diagnostic techniques, if necessary. In 79 patients metastases were discovered (32 lymph node and 47 distant metastases) within 18 months following thyroidectomy. Mean values of first Tg were significantly higher in patients with than in patients without metastases (258.9±310.6 vs 15.9±19.6 ng/ml; P<0.0001). Receiver operating characteristic (ROC) curve analysis of data revealed that for first Tg values higher than 69.7 ng/ml, the positive predictive value for the presence of metastases exceeded 90%. No statistically significant correlation was found between first Tg value and either thyroid-stimulating hormone (TSH) value or percentage of 131I uptake by residual thyroid tissue. No other parameter (age, histological type, site of metastases, 131I uptake by metastases) was significantly related to the first Tg value. We conclude that the first Tg measurement after total thyroidectomy provides a useful early diagnostic indication of metastatic disease in spite of the presence of a post-surgical thyroid remnant, and that this holds true regardless of the TSH value and WBS result. This early information is of clinical relevance for patient follow-up.


BMC Nephrology | 2003

Atherosclerotic ischemic renal disease. Diagnosis and prevalence in an hypertensive and/or uremic elderly population

Giorgio Coen; Santo Calabria; Silvia Lai; Eleonora Moscaritolo; Italo Nofroni; Giuseppe Ronga; Michele Rossi; Guido Ventroni; Daniela Sardella; Michele Ferrannini; Alvaro Zaccaria; Rosario Cianci

BackgroundAtherosclerotic ischemic renal disease is a frequent cause of end-stage renal failure leading to dialysis among the elderly; Its prevalence is inferred from autopsy or retrospective arteriographic studies. This study has been conducted on 269 subjects over 50 with hypertension and/or CRF, unrelated to other known causes of renal disease.MethodsAll 269 patients were studied either by color-flow duplex sonography (n = 238) or by renal scintigraphy (n = 224), and 199 of the 269 patients were evaluated using both of these techniques. 40 patients, found to have renal artery stenosis (RAS), were subjected to 3D-contrast enhancement Magnetic Resonance Angiography (MRA) and/or Selective Angiography (SA). An additional 23 cases, negative both to scintigraphy and to ultrasound study, underwent renal angiography (MRA and/or SA).ResultsColor-duplex sonography, carried out in 238 patients, revealed 49 cases of RAS. MR or SA was carried out in 35 of these 49 patients, and confirmed the diagnosis in 33. Color-duplex sonography showed a PPV value of 94.3% and NPV of 87.0% while renal scintigraphy, carried out in 224 patients, had a PPV of 72.2% and a NPV of 29.4%. Patients with RAS showed a higher degree of renal insufficiency compared to non stenotic patients while there were no differences in proteinuria. RAS, based on color-duplex sonography studies, was present in 11% of patients in the age group 50–59, 18% in the 60–69 and 23% at age 70 and above.ConclusionsA relatively large percentage of the elderly population with renal insufficiency and/or hypertension is affected by RAS and is at risk of developing end-stage renal failure. Color-duplex ultrasonography is a valid routine method of investigation of population at risk for renal artery stenosis.


Cancer Biotherapy and Radiopharmaceuticals | 2002

Death from differentiated thyroid carcinoma: Retrospective study of a 40-year investigation

Giuseppe Ronga; Mauro Filesi; Teresa Montesano; Francesca Fiore Melacrinis; Angelo Domenico Di Nicola; Guido Ventroni; Alfredo Antonaci; Anna Rita Vestri

Differentiated thyroid carcinoma (DTC) usually has a good prognosis, but sometimes the course of the disease results in death. The aim of the present study was to assess the effect of some variables in time to death on fatal cases in our series. A total of 83 patients with DTC who died between 1958 and 1998 from differentiated thyroid cancer were retrospectively analyzed with respect to gender, age at diagnosis, histology, percentage of (131)I uptake by postoperative thyroid remnant, site of tumor growth, and its (131)I uptake, metastases and time to death. Univariate analysis revealed a significantly shorter time to death in local recurrence when comparing local lymph node metastases and distant metastases even if neither show (131)I uptake. Multivariate analysis revealed that age at diagnosis was the most important factor in conditioning the time to death. In conclusion, in those patients who died from DTC an older age at diagnosis and presence of local recurrence influenced the time to death independently of (131)I uptake.


Physica Medica | 2017

Gamma camera calibrations for the Italian multicentre study for lesion dosimetry in 223Ra therapy of bone metastases

Massimiliano Pacilio; Bartolomeo Cassano; R. Pellegrini; Elisabetta Di Castro; Alessandra Zorz; Giuseppe De Vincentis; Guido Ventroni; Lucio Mango; Stefano Giancola; Mahila Ferrari; Marta Cremonesi; Claudia L. Bianchi; Giorgio Virotta; C. Carbonini; Patrizia Cesana; Cristian Fulcheri; Valentina Reggioli; Alessandra Ricci; Edoardo Trevisiol; Silvia Maria Anglesio; R. Pani

PURPOSE The aim was to calibrate gamma cameras in the framework of the Italian multicentre study for lesion dosimetry in 223Ra therapy of bone metastases. Equipments of several manufacturers and different models were used. METHODS Eleven gamma cameras (3/8- and 5/8-inch crystal) were used, acquiring planar static images with double-peak (82 and 154keV, 20% wide) and MEGP collimator. The sensitivity was measured in air, varying source-detector distance and source size. Transmission curves were measured, calculating the parameters used for attenuation/scatter correction with the pseudo-extrapolation number method, and assessing their variations with the source size. RESULTS Values of the calibration factor (geometric mean of both detector sensitivities) ranged from 41.1 to 113.9cps/MBq. For the smallest source (diameter of 3.5cm), the calibration factor decrease ranged from -30% to -4%, highlighting the importance of partial volume effects according to the equipment involved. The sensitivity variation with the source-detector distance, with respect to the 15cm-value, reached 10% (in absolute value) in the range 5-30cm, but fixing the distance between the two heads, the calibration factor variation with the distance from the midline was within 3.6%. Appreciable variation of the transmission curves with the source size were observed, examining the results obtained with six gamma cameras. CONCLUSION Assessments of sensitivity and transmission curve variations with source size should be regularly implemented in calibration procedures. The results of this study represent a useful compendium to check the obtained calibrations for dosimetric purposes.


Diagnostics | 2018

Dosimetry-Based Consideration on Remission and Relapse after Therapy with 223Ra-Dichloride in Castration-Resistant Prostate Cancer (CRPC) with Bone Metastases. A Case Report

Anna Mangano; Massimiliano Pacilio; Pasquale Ialongo; Alessandro Semprebene; Guido Ventroni; Lucio Mango

Here, we present the case of a 64-year-old male patient diagnosed with castration-resistant prostate cancer (CRPC) with bone metastasis, treated with abiraterone prednisone/prednisolone in combination with 223Ra-dichloride therapy, who had remission and a subsequent relapse of bone metastasis on repeated bone scans after therapy. We also discuss the possibility of continuing the 223Ra-dichloride therapy over the six planned administrations by administering other cycles at the same dose or at higher doses, if shown to be devoid of a significant increase in side effects, based on dosimetry considerations.


The Journal of Nuclear Medicine | 1998

Role of initial iodine-131 whole-body scan and serum thyroglobulin in differentiated thyroid carcinoma metastases.

Mauro Filesi; Alberto Signore; Guido Ventroni; Francesca Fiore Melacrinis; Giuseppe Ronga


European Journal of Nuclear Medicine and Molecular Imaging | 2016

Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting 223 Ra-dichloride

Massimiliano Pacilio; Guido Ventroni; Giuseppe De Vincentis; Bartolomeo Cassano; R. Pellegrini; Elisabetta Di Castro; Viviana Frantellizzi; Giulia Anna Follacchio; Tatiana Garkavaya; Leda Lorenzon; Pasquale Ialongo; R. Pani; Lucio Mango


The Journal of Nuclear Medicine | 2000

Micronucleus yield and colorimetric test as indicators of damage in patients' lymphocytes after 131I therapy

C. Catena; Daniela Conti; Giorgio Trenta; Enzo Righi; Francesco Breuer; Francesca Fiore Melacrinis; Teresa Montesano; Guido Ventroni; Giuseppe Ronga


Annals of Nuclear Medicine | 2016

A case report of image-based dosimetry of bone metastases with Alpharadin ( 223 Ra-dichloride) therapy: inter-fraction variability of absorbed dose and follow-up

Massimiliano Pacilio; Guido Ventroni; Bartolomeo Cassano; Pasquale Ialongo; Leda Lorenzon; Elisabetta Di Castro; Federica Recine; Cora N. Sternberg; Lucio Mango


European Journal of Nuclear Medicine and Molecular Imaging | 2014

Improving the dose–myelotoxicity correlation in radiometabolic therapy of bone metastases with 153Sm-EDTMP

Massimiliano Pacilio; Guido Ventroni; Chiara Basile; Pasquale Ialongo; Domenico Becci; Lucio Mango

Collaboration


Dive into the Guido Ventroni's collaboration.

Top Co-Authors

Avatar

Giuseppe Ronga

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Bartolomeo Cassano

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Mauro Filesi

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Leda Lorenzon

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Teresa Montesano

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Alberto Signore

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

R. Pani

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

R. Pellegrini

Sapienza University of Rome

View shared research outputs
Researchain Logo
Decentralizing Knowledge